Mounjaro UK: a friendly guide to tirzepatide for weight loss

Start with what you want treatment to help you do

Perhaps you want walking to feel easier, to manage a weight-related condition, or to spend less of the day preoccupied with food. Bring those goals to the consultation. A number on the scales can be useful, but it does not describe everything that matters to you.

Tirzepatide acts on GIP and GLP-1 receptors involved in appetite and blood-sugar regulation. Its adult weight-management licence covers obesity, or overweight with a weight-related health condition. Meeting a BMI threshold is only one part of an assessment; your medical history and current medicines still matter. NHS funding rules are narrower than the medicine's licence.

Who can be considered for treatment?

For adult weight management, the UK licence covers an initial BMI of at least 30, or at least 27 with a weight-related health problem. Examples include high blood pressure, abnormal blood fats and type 2 diabetes. These are starting criteria for a clinical assessment, not a prescription checklist you can complete yourself.

Tell the prescriber about previous pancreatitis, significant digestive problems, diabetes medicines, allergies and pregnancy plans. They will decide what these mean for your care. Mounjaro should not be used during pregnancy. If breastfeeding or planning to breastfeed, discuss the current medicine-specific advice with your clinician before starting or continuing. NHS assessment follows additional rules and local arrangements; private access still requires a proper prescription and clinical review. This adult guide does not cover prescribing for children.

What does the evidence mean for your expectations?

Clinical studies show that tirzepatide can help eligible participants lose more weight than a placebo when both groups receive diet and activity support. Results depend on the study population, treatment period and how the analysis deals with people who stop treatment. A headline percentage leaves out much of that context.

Ask your clinician how the evidence relates to your health and what progress they would consider meaningful. Agree a review point rather than a deadline for reaching a particular body size. Some people do not get enough benefit or cannot tolerate treatment. Continuing should be a decision about benefit and burden, with attention to nutrition and daily functioning as well as weight. Weight may return after stopping, so maintenance support deserves an early conversation.

Make the first review about more than kilograms

Keep a short note of how you feel between appointments: appetite, meals you can manage, any sickness or bowel changes, and whether normal activities feel easier or harder. A note such as ‘I struggled to eat lunch three days this week’ is more useful to a prescriber than simply saying treatment is going well.

Ask what progress would justify continuing and what would trigger a change. Trial averages cannot tell you how much weight you will lose, and stronger appetite suppression is not a target in itself. If eating, drinking or everyday functioning becomes difficult, contact your treatment team rather than waiting for your next routine review.

Use the prescription safely and know when to act

Mounjaro is a weekly injection. Follow the instructions for the pen supplied to you; your prescriber sets the treatment schedule and any changes. If you have a problem with the device or are unsure whether a full injection was delivered, contact the pharmacy and check the leaflet rather than guessing.

Common digestive effects include nausea, vomiting and bowel changes. Stop the medicine and seek urgent medical help for severe, persistent abdominal pain, especially if it spreads to your back. Call 999 for breathing difficulty or swelling of the tongue or throat. If you take the contraceptive pill, discuss adding a barrier method, such as condoms, or switching to non-oral contraception for four weeks after starting Mounjaro and four weeks after each dose increase. The UK patient leaflet explains this precaution. Our Mounjaro contraception guide helps you prepare that conversation. Tell surgical teams about treatment before anaesthesia or sedation.

What if I miss a Mounjaro injection?

For a single missed dose, the Mounjaro patient leaflet says to inject when you remember if you are no more than four days late. If you are later than that, leave the missed dose out. In either case, use the next dose on your usual weekly day. Never double up, and leave at least three days between injections.

If you have missed more than one dose, or cannot tell when you last injected, ask your prescriber or pharmacist before restarting. Keep your pen and dispensing label handy when you call. Read our missed Mounjaro dose guide for help with that conversation.

Think past the first prescription

Before committing, ask who will answer clinical questions, how repeat prescriptions are reviewed and what support is available if you need to stop. If paying privately, write down the usual ongoing cost, consultation charges and delivery fees as well as any introductory discount. The cheapest listed price says nothing about whether a medicine is suitable for you.

Read the patient leaflet supplied with your own pen and ask for a demonstration if anything is unclear. Agree storage, travel and sharps-disposal arrangements with the pharmacy. Do not change treatment or extract leftover liquid to stretch a prescription. A workable care plan should also explain what happens if supply, cost or your circumstances change.